Mr Stephan Veldkamp Germany

Strathos Pharma is a privately owned company group which is active within the following business fields:

Marketing and distribution of OTC brands in Germany, Switzerland and Austria with specific strengths

in the field of: Cough & Cold, Sinus, Respiratory and Allergy products (Siemens & CO: Emser®); herbal

(medicinal) teas and herbal products (Sidroga®) both in pharmacies and drug stores (Emsan®).

The company group´s annual turnover exceeds 55 Mio. EUR.

We offer:

Strong sales and marketing structures in our target markets (Germany, Switzerland and Austria) with 50

sales representatives and about 8.000 permanent product displays (shop in shop system) in pharmacies

and key acount Management of Drugstores.

We are interested in:

In-Licensing of products for extension of our OTC portfolio in Germany, Switzerland and Austria.

Main target areas for natural products (e.g. phyto medicine): Cough & Cold, Sinus, Respiratory, Allergy,

Sleep disorders, Mental Stress, CNS, Female Health, Male Health, Gastro - all regulatory pathways

(medicinal products, medical device, etc.)

Additionally substance based medical devices for all indications

Advanced development projects in the upper mentioned therapeutic categories - generic and innovative.

Mr Stephan Veldkamp
Strathos Pharma Group
Business Development / Licensing-In Manager 

Ms Susanna Vera Spain

Website:
www.esteve.com
ESTEVE PHARMACEUTICALS
ALLIANCE MANAGEMENT DIRECTOR 

Clara Vitaller Germany

Helm AG is a Hamburg- based, privately owned company and represented by own subsidiaries in more

than 30 countries worldwide.

In cooperation with highly acclaimed international partners, Helm offers developments of generic

pharmaceuticals, IP researches, registrations of high quality e-CTD dossiers, launch and life cycle

management.

Our global presence and extensive variety of excellent service functions mean that Helm is your ideal

partner for all stages of the product life cycle from the initial idea generation through to the launch and

supply of the medicinal product.

We offer:

-High quality e-CTD dossiers per current EU-requirements and international registration strategies.

-Tailor made portfolio ideas.

- Excellent project management

- Collaborations for innovative technology platforms.

We are interested in:

- Identifying out-licensing and co-operation opportunities - especially for EU, Nordics, UK, LATAM, MENA

& CIS markets.

- Exploring product & brand acquisition opportunities in the targeted territories.

- Divestment of companies

We are NOT interested in:

- Regulatory Services

- CRO + CMO Services

Helm AG
LinkedIn logo Licensing Manager 

Dr Johannes Voegel Switzerland

Galderma
Head of External Early-Stage Opportunities 

Mr Jai Wall United States

Sebela
VP 

Mr Oren Weininger Switzerland

Fair-Med Healthcare AG
CEO 

Dr Oren Weininger Switzerland

Fair-Med Healthcare AG
CEO 

Mrs Alexandra Wollersheim Germany

Staatz Business Development & Strategy
Business Development Manager 

Ms Kefan Yao China

Sanhome was founded in 1996; now it has become a key high-tech pharmaceutical enterprise in China, concentrating on drug development, production and marketing. 

Sanhome mainly focuses on drugs for cancer, infection and central nervous system diseases. We have approximately 20 projects at this stage. 3 of them are in clinical trials, and 4 molecules are in pre-clinical stages. More than a dozen effective molecules have been identified.

The mission of Sanhome is Let more people enjoy the joy of health and the enterprise vision is To become the most trustworthy enterprise for doctors and patients by helping patients prolong their life span and improve their quality of life.

Nanjing Sanhome Pharmaceutical Co. Ltd
BD manager 

Dr Michael Yeomans United States

Partners in Pharma LLC is a private partnership that offers independent strategic advice and business development support to the global pharmaceutical industry. The company is based in New Jersey, USA, but works with clients across the globe to help them grow their business.


We develop long-term relationships with our clients based on mutual trust and respect.  This enables us to better understand our clients and their needs and to provide them with more creative and comprehensive ideas.

Partners in Pharma LLC
President, Partners in Pharma LLC